Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
featured
Published in Oncology

Journal Scan / Research · May 29, 2015

Azacitidine vs Conventional Care in Older Patients With AML

Blood

 

 Save  Recommend
 Share

Additional Info

Blood
International Phase 3 Study of Azacitidine vs Conventional Care Regimens in Older Patients With Newly Diagnosed AML With >30% Blasts
Blood 2015 May 18;[EPub Ahead of Print], H Dombret, JF Seymour, A Butrym, A Wierzbowska, D Selleslag, JH Jang, R Kumar, J Cavenagh, AC Schuh, A Candoni, C Récher, I Sandhu, T Bernal Del Castillo, HK Al-Ali, G Martinelli, J Falantes, R Noppeney, RM Stone, MD Minden, H McIntyre, S Songer, LM Lucy, CL Beach, H Döhner

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated